BASEL (Reuters) - Swiss drugmaker posted a slight fall in sales in the first half, as the strong Swiss franc put the brakes on solid growth of its breast cancer medicines.
Reuters: Top News, Reuters
Thu, 07/24/2014 - 12:29am
BASEL (Reuters) - Swiss drugmaker posted a slight fall in sales in the first half, as the strong Swiss franc put the brakes on solid growth of its breast cancer medicines.